T1	Condition 338 358	macular degeneration
T2	Condition-Name 338 358	macular degeneration
E1	Condition:T1 Name:T2
T3	Condition 801 829	systemic lupus erythematosus
T4	Condition-Name 801 829	systemic lupus erythematosus
E3	Condition:T3 Name:T4
T5	Condition 259 267	glaucoma
T6	Condition-Name 259 267	glaucoma
E5	Condition:T5 Name:T6
T7	Condition 523 542	Ocular inflammation
T8	Condition-Name 523 542	Ocular inflammation
E7	Condition:T7 Name:T8
T11	Condition 1122 1137	organic disease
T12	Condition-Name 1122 1137	organic disease
E11	Condition:T11 Name:T12 Severity:T107 Severity2:T108
T13	Condition 547 561	ocular disease
T14	Condition-Name 547 561	ocular disease
E13	Condition:T13 Name:T14
T15	Observation 97 106	ametropia
T16	Observation-Name 97 106	ametropia
E15	Observation:T15 Name:T16 Eq-Comparison:E6
T17	Condition 835 844	Porphyria
T18	Condition-Name 835 844	Porphyria
E17	Condition:T17 Name:T18
T19	Condition 846 854	Vitiligo
T20	Condition-Name 846 854	Vitiligo
E19	Condition:T19 Name:T20
T21	Condition 882 890	Albinism
T22	Condition-Name 882 890	Albinism
E21	Condition:T21 Name:T22
T23	Condition 920 928	epilepsy
T24	Condition-Name 920 928	epilepsy
E23	Condition:T23 Name:T24
T25	Condition 1070 1078	disorder
T26	Condition-Name 1070 1078	disorder
E25	Condition:T25 Name:T26
T27	Condition 278 282	POAG
T28	Condition-Name 278 282	POAG
E27	Condition:T27 Name:T28
T29	Condition 300 304	POAG
T30	Condition-Name 300 304	POAG
E29	Condition:T29 Name:T30
T31	Life-Stage-And-Gender 25 28	men
T32	Condition 360 363	AMD
T33	Condition-Name 360 363	AMD
E32	Condition:T32 Name:T33
T34	Condition 385 388	AMD
T35	Condition-Name 385 388	AMD
E34	Condition:T34 Name:T35
T36	Condition 426 429	AMD
T37	Condition-Name 426 429	AMD
E36	Condition:T36 Name:T37 Stage:E14 Stage2:E16
T38	Condition 830 833	SLE
T39	Condition-Name 830 833	SLE
E38	Condition:T38 Name:T39
T40	Eq-Operator 313 315	<=
A1	Eq-Operator-Value T40 LTEQ
T41	Eq-Temporal-Unit 52 57	years
A2	Eq-Temporal-Unit-Value T41 year
T42	Eq-Temporal-Unit 683 689	months
A3	Eq-Temporal-Unit-Value T42 month
T43	Eq-Temporal-Unit 958 964	months
A4	Eq-Temporal-Unit-Value T43 month
T44	Age 39 43	aged
E39	Age:T44 Eq-Comparison:E4
T45	Eq-Value 49 51	18
T46	Eq-Value 113 114	3
T47	Eq-Value 316 318	10
T48	Eq-Value 681 682	3
T49	Eq-Value 956 957	3
T50	Eq-Comparison 313 321	<= 10 dB
E40	Eq-Comparison:T50 Operator:T40 Value:T47 Unit:T65
A5	Life-Stage-And-Gender-Type T31 male
T51	Life-Stage-And-Gender 33 38	women
A6	Life-Stage-And-Gender-Type T51 female
T52	Or 29 32	and
E2	Or:T52 Arg:T31 Arg2:T51
T53	Eq-Comparison 44 57	over 18 years
E4	Eq-Comparison:T53 Temporal-Unit:T41 Operator:T54 Value:T45
T54	Eq-Operator 44 48	over
A7	Eq-Operator-Value T54 GT
T55	Eq-Comparison 107 123	below 3 diopters
E6	Eq-Comparison:T55 Unit:T57 Operator:T56 Value:T46
T56	Eq-Operator 107 112	below
A8	Eq-Operator-Value T56 LT
T57	Eq-Unit 115 123	diopters
T58	Observation 180 187	healthy
E8	Observation:T58 Name:T59
T59	Observation-Name 180 187	healthy
T60	Observation 212 235	ophthalmologic findings
E10	Observation:T60 Name:T61 Polarity:T62
T61	Observation-Name 212 235	ophthalmologic findings
T62	Polarity 205 211	normal
A9	Polarity-Value T62 normal
R1	Abbrev-Of Arg1:E27 Arg2:E5	
T63	Observation 310 312	MD
E12	Observation:T63 Name:T64 Eq-Comparison:E40
T64	Observation-Name 310 312	MD
T65	Eq-Unit 319 321	dB
R2	Abbrev-Of Arg1:E32 Arg2:E1	
T69	Condition 471 484	abnormalities
E20	Condition:T69 Name:T70
T70	Condition-Name 471 484	abnormalities
T71	Assertion 485 495	preventing
E22	Assertion:T71 Asserted:E26
A10	Assertion-Type-Value E22 hypothetical
T72	Observation 505 517	measurements
E24	Observation:T72 Stability:T118
T73	Negation 485 495	preventing
E26	Negation:T73 Negates:T118
R3	Caused-By Arg1:E26 Arg2:E20	
T74	Or 543 546	and
E28	Or:T74 Arg:E7 Arg2:E13
T9	Drug 606 633	photosensitizing medication
E9	Drug:T9 Name:T10 Temporality:E33
T10	Drug-Name 606 633	photosensitizing medication
T75	Drug 635 651	phototoxic drugs
E30	Drug:T75 Name:T76
T76	Drug-Name 635 651	phototoxic drugs
T77	Drug 653 672	photoallergic drugs
E31	Drug:T77 Name:T78
T78	Drug-Name 653 672	photoallergic drugs
R4	Example-Of Arg1:E30 Arg2:E9	
R5	Example-Of Arg1:E31 Arg2:E9	
T79	Eq-Comparison 681 689	3 months
E33	Eq-Comparison:T79 Temporal-Unit:T42 Value:T48
T80	Study 704 709	study
E35	Study:T80 
T81	Temporal-Connection 690 699	preceding
E37	Temporal-Connection:T81 Arg2:E35 Arg:E33
A11	Temporal-Connection-Type-Value E37 before
T82	Condition 731 740	condition
E41	Condition:T82 
T83	Assertion 750 764	possibility of
E42	Assertion:T83 Asserted:E43
A12	Assertion-Type-Value E42 possible
T84	Condition 773 789	photosensitivity
E43	Condition:T84 Name:T85
T85	Condition-Name 773 789	photosensitivity
R6	Caused-By Arg1:E43 Arg2:E41	
R7	Example-Of Arg1:E3 Arg2:E41	
R8	Example-Of Arg1:E38 Arg2:E41	
R9	Example-Of Arg1:E17 Arg2:E41	
R10	Example-Of Arg1:E19 Arg2:E41	
T86	Condition 856 877	Xeroderma Pigmentosum
E44	Condition:T86 Name:T87
T87	Condition-Name 856 877	Xeroderma Pigmentosum
R11	Example-Of Arg1:E44 Arg2:E41	
T88	Or 878 881	and
E45	Or:T88 Arg:E44 Arg2:E21
R12	Example-Of Arg1:E21 Arg2:E41	
T89	Procedure 934 948	Ocular surgery
E46	Procedure:T89 Name:T90 Temporality:E47
T90	Procedure-Name 934 948	Ocular surgery
T91	Eq-Comparison 956 964	3 months
E47	Eq-Comparison:T91 Temporal-Unit:T43 Value:T49
T92	Study 979 984	study
E48	Study:T92 
T93	Temporal-Connection 965 974	preceding
E49	Temporal-Connection:T93 Arg:E47 Arg2:E48
A13	Temporal-Connection-Type-Value E49 before
T94	Condition 990 999	Pregnancy
E50	Condition:T94 Name:T95
T95	Condition-Name 990 999	Pregnancy
T96	Condition 1009 1018	pregnancy
E51	Condition:T96 Name:T97
T97	Condition-Name 1009 1018	pregnancy
T98	Assertion 1001 1008	planned
E52	Assertion:T98 Asserted:E51
A14	Assertion-Type-Value E52 intention
T99	Condition 1022 1031	lactating
E53	Condition:T99 Name:T100
T100	Condition-Name 1022 1031	lactating
T101	Or 1019 1021	or
E54	Or:T101 Arg:E51 Arg2:E53
T102	Procedure 1052 1060	surgical
E55	Procedure:T102 Name:T103 Temporality:E64
T103	Procedure-Name 1052 1060	surgical
T104	Condition 1082 1089	disease
E56	Condition:T104 Name:T105
T105	Condition-Name 1082 1089	disease
T106	Or 1079 1081	or
E57	Or:T106 Arg:E25 Arg2:E56
T107	Severity 1115 1121	severe
A15	Severity-Value T107 severe
T109	Modifier 1107 1114	chronic
E59	Modifier:T109 Modifies:T12
T110	Or 1104 1106	or
E60	Or:T110 Arg2:E59 Arg:T108
R13	Example-Of Arg1:E11 Arg2:E56	
T66	Eq-Comparison 416 425	stage III
E14	Eq-Comparison:T66 Unit:T67 Value:T68
T67	Eq-Unit 416 421	stage
T68	Eq-Value 422 425	III
T111	Eq-Comparison 404 412	stage II
E16	Eq-Comparison:T111 Unit:T112 Value:T113
T112	Eq-Unit 404 409	stage
T113	Eq-Value 410 412	II
T114	Or 413 415	or
E18	Or:T114 Arg:E16 Arg2:E14
T115	Modifier 381 384	dry
E61	Modifier:T115 Modifies:T35
T116	Modifier 326 337	age-related
E62	Modifier:T116 Modifies:T2
T117	Modifier 240 258	primary open angle
E63	Modifier:T117 Modifies:T6
T118	Stability 496 504	reliable
A16	Stability-Value T118 stable
T119	Eq-Comparison 1061 1068	history
E64	Eq-Comparison:T119 Temporal-Period:T120
T120	Eq-Temporal-Period 1061 1068	history
A17	Eq-Temporal-Period-Value T120 past
T108	Severity 1098 1103	acute
A18	Severity-Value T108 severe
